Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)
CUSIP: 04746L104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 9,614,000
- Total 13F shares
- 22,193,550
- Share change
- +488,949
- Total reported value
- $58,807,500
- Put/Call ratio
- 133%
- Price per share
- $2.65
- Number of holders
- 65
- Value change
- +$1,275,233
- Number of buys
- 15
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04746L104:
Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
56%
|
5,402,964
|
$14,804,121 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
33%
|
3,153,807
|
$8,641,431 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
17%
|
1,634,433
|
$4,478,347 | — | 31 Mar 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
16%
|
1,492,792
|
$4,090,250 | — | 31 Mar 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
16%
|
1,492,792
|
$4,090,250 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
9.4%
|
900,000
|
$2,466,000 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.9%
|
852,715
|
$2,336,439 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.9%
|
667,278
|
$1,828,342 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
5.7%
|
549,938
|
$1,505,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
5.2%
|
497,475
|
$1,363,082 | — | 31 Mar 2024 | |
| Pathstone Holdings, LLC |
13F
|
Company |
5.1%
|
492,226
|
$1,348,699 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.6%
|
438,594
|
$1,201,747 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
4.4%
|
425,605
|
$1,166,158 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
3.8%
|
369,500
|
$1,012,430 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.1%
|
300,237
|
$822,866 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.7%
|
262,324
|
$719,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.4%
|
228,402
|
$625,821 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
1.9%
|
180,000
|
$493,200 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.8%
|
176,230
|
$483,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
175,973
|
$482,166 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
1.7%
|
163,589
|
$448,234 | — | 31 Mar 2024 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
1.5%
|
147,309
|
$403,627 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.5%
|
146,770
|
$402,150 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
141,661
|
$388,151 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1.4%
|
131,666
|
$360,765 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
108,114
|
$296,232 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
107,781
|
$295,320 | — | 31 Mar 2024 | |
| Hans Moebius |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
91,482
|
$266,213 | — | 04 Jan 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.97%
|
93,421
|
$255,974 | — | 31 Mar 2024 | |
| Bristlecone Advisors, LLC |
13F
|
Company |
0.89%
|
85,306
|
$233,739 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.78%
|
75,389
|
$206,566 | — | 31 Mar 2024 | |
| Clarius Group, LLC |
13F
|
Company |
0.56%
|
53,551
|
$146,730 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
53,220
|
$145,823 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
42,499
|
$116,447 | — | 31 Mar 2024 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.44%
|
42,079
|
$115,296 | — | 31 Mar 2024 | |
| BAILARD, INC. |
13F
|
Company |
0.42%
|
40,473
|
$110,896 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
40,051
|
$109,740 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.37%
|
36,045
|
$98,763 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.37%
|
35,607
|
$97,563 | — | 31 Mar 2024 | |
| EASTERLY INVESTMENT PARTNERS LLC |
13F
|
Company |
0.35%
|
33,500
|
$91,790 | — | 31 Mar 2024 | |
| Integrity Financial Corp /WA |
13F
|
Company |
0.34%
|
32,786
|
$89,834 | — | 31 Mar 2024 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.33%
|
32,200
|
$88,228 | — | 31 Mar 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.25%
|
24,200
|
$66,308 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
23,667
|
$64,848 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.22%
|
21,278
|
$58,302 | — | 31 Mar 2024 | |
| Mirador Capital Partners LP |
13F
|
Company |
0.21%
|
20,660
|
$56,608 | — | 31 Mar 2024 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.21%
|
20,616
|
$56,488 | — | 31 Mar 2024 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.21%
|
20,538
|
$56,274 | — | 31 Mar 2024 | |
| SIMON QUICK ADVISORS, LLC |
13F
|
Company |
0.21%
|
20,538
|
$56,274 | — | 31 Mar 2024 | |
| Sargent Investment Group, LLC |
13F
|
Company |
0.21%
|
19,753
|
$54,123 | — | 31 Mar 2024 |
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2024
As of 30 Jun 2024,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,193,550 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Propel Bio Management, LLC, Simplify Asset Management Inc., WASATCH ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, BlackRock Inc., and DIMENSIONAL FUND ADVISORS LP.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
73
Q2 2024 holders
65
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.